Recombinant outer membrane secretin PilQ(406-770) as a vaccine candidate for serogroup B Neisseria meningitidis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-02-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2011.12.076PMID 22234267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Protein Protocols Handbook

  2009cited by this paper
• Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.

  2009cited by this paper
• Meningococcal protein antigens and vaccines.

  2009cited by this paper
• Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines

  2008cited by this paper
• Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

  2008cited by this paper
• Serum Bactericidal Antibody Responses to Meningococcal Polysaccharide Vaccination as a Basis for Clinical Classification of Common Variable Immunodeficiency

  2008cited by this paper
• Immunity to Neisseria meningitidis Group B in Adults despite Lack of Serum Bactericidal Antibody

  2007cited by this paper
• Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults.

  2007cited by this paper
• The outer membrane secretin PilQ from Neisseria meningitidis binds DNA

  2007cited by this paper
• Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies.

  2007cited by this paper
• Additive and Synergistic Bactericidal Activity of Antibodies Directed against Minor Outer Membrane Proteins of Neisseria meningitidis

  2007cited by this paper
• Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.

  2006cited by this paper
• Topology of the outer-membrane secretin PilQ from Neisseria meningitidis.

  2006cited by this paper
• A review of vaccine research and development: meningococcal disease.

  2006cited by this paper
• Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions.

  2006cited by this paper
• Evaluation of Recombinant Lipidated P2086 Protein as a Vaccine Candidate for Group B Neisseria meningitidis in a Murine Nasal Challenge Model

  2005cited by this paper
• Identification of novel antigens that protect against systemic meningococcal infection.

  2005cited by this paper
• Interaction with Type IV Pili Induces Structural Changes in the Bacterial Outer Membrane Secretin PilQ*

  2005cited by this paper
• Cross-Reactivity of Antibodies against PorA after Vaccination with a Meningococcal B Outer Membrane Vesicle Vaccine

  2003cited by this paper
• Three-Dimensional Structure of the Neisseria meningitidis Secretin PilQ Determined from Negative-Stain Transmission Electron Microscopy

  2003cited by this paper
• Analysis of Pathogen-Host Cell Interactions in Purpura Fulminans: Expression of Capsule, Type IV Pili, and PorA by Neisseria meningitidis In Vivo

  2002cited by this paper
• Analysis of the PilQ Secretin from Neisseria meningitidis by Transmission Electron Microscopy Reveals a Dodecameric Quaternary Structure

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• The pilus colonization factor of pathogenic neisserial species: organelle biogenesis and structure/function relationships--a review.

  1997cited by this paper
• Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group

  1997cited by this paper
• Characterization of serogroup A and B strains of Neisseria meningitidis with serotype 4 and 21 monoclonal antibodies and by multilocus enzyme electrophoresis

  1991cited by this paper
• Ultrastructure of Pili and Annular Structures on the Cell Wall Surface of Neisseria meningitidis

  1974cited by this paper

• Antigenicity in mice of a recombinant Neisseria gonorrhoeae MafA 2/3 protein

  2025cites this paper
• Innovations, challenges, and gaps in the development of an effective vaccine against Neisseria gonorrhoeae, a narrative review.

  2025cites this paper
• Sweet complexity: O-linked protein glycosylation in pathogenic Neisseria

  2024cites this paper
• Neisseria gonorrhoeae vaccines: a contemporary overview

  2024cites this paper
• An immunoproteomics study of antisera from patients with gonorrhea identifies novel Neisseria gonorrhoeae proteins

  2023cites this paper
• Synergistic activity of antibodies in the multicomponent 4CMenB vaccine

  2022cites this paper
• The protective efficacy of forty outer membrane proteins based DNA vaccines against Aeromonas hydrophila in zebrafish

  2022cites this paper
• The potential utility of liposomes for Neisseria vaccines

  2021cites this paper
• Meningococcal Detoxified Outer Membrane Vesicle Vaccines Enhance Gonococcal Clearance in a Murine Infection Model.

  2021cites this paper
• Extraction and biological evaluation of external membrane vesicles of Brucella abortus as a candidate for brucellosis vaccine

  2020cites this paper
• The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae

  2020cites this paper
• Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis

  2019cites this paper
• Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine

  2019cites this paper
• Die humorale Immunantwort

  2018cites this paper
• Quantitative Proteomics of the 2016 WHO Neisseria gonorrhoeae Reference Strains Surveys Vaccine Candidates and Antimicrobial Resistance Determinants*

  2018cites this paper
• Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci

  2018cites this paper
• Molecular characterization and Functional Analysis of the PilQ380-706: a Novel Secretin Domain in Pseudomonas aeruginosa

  2018cites this paper
• Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from Pseudomonas aeruginosa in mice

  2017cites this paper
• A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C

  2017cites this paper
• Novel approaches to Neisseria meningitidis vaccine design.

  2017cites this paper
• A novel recombinant vaccine candidate comprising PBP2a and autolysin against Methicillin Resistant Staphylococcus aureus confers protection in the experimental mice

  2017cites this paper
• Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development.

  2017cites this paper
• Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development

  2016cites this paper
• Evaluation of the immunogenic property of NT H. influenzae protein D with Neisseria meningitidis OMV in BALB/c.

  2016cites this paper
• How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines

  2015cites this paper
• Vaccines against gonorrhea: current status and future challenges.

  2014cites this paper
• The type 2 secretion and type 4 pilus systems of Escherichia coli

  2013cites this paper
• Whole Genome Sequence of the Treponema Fribourg-Blanc: Unspecified Simian Isolate Is Highly Similar to the Yaws Subspecies

  2013cites this paper
• Vaccine research for gonococcal infections: where are we?

  2013cites this paper
• Structural Characterization of Type IV Pilus Biogenesis Proteins

  2012cites this paper
• Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice

  2012cites this paper